[HTML][HTML] Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers

S Haddadzadegan, F Dorkoosh… - Advanced drug delivery …, 2022 - Elsevier
The oral administration of therapeutic peptides and proteins is favoured from a patient and
commercial point of view. In order to reach the systemic circulation after oral administration …

Self-nano-emulsifying drug-delivery systems: From the development to the current applications and challenges in oral drug delivery

AB Buya, A Beloqui, PB Memvanga, V Préat - Pharmaceutics, 2020 - mdpi.com
Approximately one third of newly discovered drug molecules show insufficient water
solubility and therefore low oral bio-availability. Self-nano-emulsifying drug-delivery systems …

Hydrophobic ion pairing: encapsulating small molecules, peptides, and proteins into nanocarriers

KD Ristroph, RK Prud'homme - Nanoscale advances, 2019 - pubs.rsc.org
Hydrophobic ion pairing has emerged as a method to modulate the solubility of charged
hydrophilic molecules ranging in class from small molecules to large enzymes. Charged …

SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs

A Mahmood, A Bernkop-Schnürch - Advanced Drug Delivery Reviews, 2019 - Elsevier
Since the development of self-emulsifying drug delivery systems (SEDDS) in 1980's, they
attract the attention of researchers in order to confront the challenge of poor water-solubility …

Hydrophobic ion pairing: Key to highly payloaded self-emulsifying peptide drug delivery systems

J Griesser, G Hetényi, M Moser, F Demarne… - International journal of …, 2017 - Elsevier
Aim The aim of this study was the formation and characterization of various ion pairs of
therapeutic peptides with different surfactants in order to reach a high payload in self …

Self-emulsifying drug delivery system: Mucus permeation and innovative quantification technologies

M Abdulkarim, PK Sharma, M Gumbleton - Advanced drug delivery reviews, 2019 - Elsevier
Mucus is a dynamic barrier which covers and protects the underlying mucosal epithelial
membrane against bacteria and foreign particles. This protection mechanism extends to …

Recent progress in hydrophobic ion-pairing and lipid-based drug delivery systems for enhanced oral delivery of biopharmaceuticals

G Noh, T Keum, S Bashyal, JE Seo, L Shrawani… - Journal of …, 2022 - Springer
Background The biopharmaceuticals market has grown rapidly in recent years owing to the
low toxicity and high therapeutic efficacy of peptide and protein drugs. However, due to their …

Advanced formulations for intranasal delivery of biologics

J Rohrer, N Lupo, A Bernkop-Schnürch - International Journal of …, 2018 - Elsevier
Introduction The global biologics market has been ever increasing over the last decades
and is predicted to top Euro 350 by 2020. Facing this scenario, the parenteral route of …

Challenges and opportunities in delivering oral peptides and proteins

H Peng, J Wang, J Chen, Y Peng, X Wang… - Expert opinion on …, 2023 - Taylor & Francis
Introduction Rapid advances in bioengineering enable the use of complex proteins as
therapeutic agents to treat diseases. Compared with conventional small molecule drugs …

Strategies to target the cancer driver MYC in tumor cells

LI Weber, M Hartl - Frontiers in Oncology, 2023 - frontiersin.org
The MYC oncoprotein functions as a master regulator of cellular transcription and executes
non-transcriptional tasks relevant to DNA replication and cell cycle regulation, thereby …